EverCommerce has now reported Q2 2026 results, the stock sits roughly flat on the week at $11.97, and the borrow market has not loosened by a single meaningful basis point.
The lending story is the same one that has defined this name all month — and it has not resolved post-earnings as shorts might have hoped. Availability has dropped to 0.71%, meaning roughly one share remains lendable for every 140 already out on loan. That is tighter than the 1.1% flagged before the print and back in the range of the mid-July readings that sat between 0.04% and 0.66%. Cost to borrow remains at 56.4% annualised — down modestly from the week's high of 60.1% but still running near the elevated plateau that has persisted since late June, when it was closer to 28%. The ORTEX short score is 95.5, essentially unchanged across every session of the past two weeks. That consistency is itself the signal: this is not a pre-event spike that printed and then unwound. The lending market has absorbed the earnings release without flinching. For context, correlated peers ALRM and VERX borrow at well under 1% — EVCM's 56% rate is structurally idiosyncratic, not sector-wide.
The options market is heavily skewed to puts but not unusually so relative to its own recent history. The put/call ratio is 4.15, fractionally above its 20-day average of 4.07 and only 0.4 standard deviations from normal — the options market is not sending a fresh signal this week. It has been defensively positioned throughout the rally, and that has not changed around the print. The 52-week range on the PCR runs from 0.02 to 16.5, making the current reading look entirely unremarkable in context.
The Street remains split, with analyst data now running roughly three months old following the last cluster of moves in early-to-mid May. The freshest available action had Canaccord lifting its target to $13 while reiterating Buy, and Goldman maintaining its Sell with an $8 target — a gap that frames the debate neatly. The consensus mean target of $11.07 sits slightly below the current price of $11.97, implying the average analyst sees modest downside from here. Factor scores are not supportive: EPS surprise ranks in the 30th percentile, forward EPS momentum in the 29th, and the short score factor sits at zero — a reflection of the structurally hostile borrow environment rather than any fundamental view. The P/E has expanded to 16.5x, up roughly three points over the past month on the back of the 20% price gain, though EV/EBITDA at 13.4x has been relatively stable.
The ownership picture adds a complicating overlay. PSG Equity and Silver Lake together hold over 86% of shares between them, which goes a long way toward explaining why the free float is so thin and the borrow pool so exhausted — there simply is not much stock available to lend. Against that backdrop, founder and CEO Eric Remer has been selling steadily, with transactions recorded on at least five separate dates in July totalling shares across seven disclosed sales. President Matthew Feierstein has also been selling, with purchases recorded for him in the institutional data suggesting a complex picture of option exercises and secondary disposals. Net insider activity over 90 days is positive in share count terms at roughly 265,000 shares — but the recent directional flow from the two most senior executives has been consistently out of the stock.
The question now is whether the post-earnings period brings any relief to the borrow market, or whether the exhausted lending pool persists as the structural backdrop for EVCM through the rest of the quarter.
See the live data behind this article on ORTEX.
Open EVCM on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
